Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).

Clinical trial NCT02045212 · COMPLETED

Trial details

NCT number: NCT02045212
Sponsor: Regenera Pharma Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-arteritic Ischemic Optic Neuropathy Optic Nerve Injuries

Start date: 2014-02-01
Primary completion: 2016-08-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.